BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6430710)

  • 21. The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
    Gibson PR; Jewell DP
    Clin Exp Immunol; 1985 Jul; 61(1):160-8. PubMed ID: 2412737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities.
    Abrams SI; Brahmi Z
    J Immunol; 1988 Mar; 140(6):2090-5. PubMed ID: 3279127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
    Thiele DL; Lipsky PE
    J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
    Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H; Tompkins WA
    J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.
    Jones RA; Richards SJ; Patel D; Scott CS
    Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A; Pantaleo G; Mingari MC; Melioli G; Moretta L; Cerottini JC
    Eur J Immunol; 1984 Feb; 14(2):121-5. PubMed ID: 6230242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J; Saksela E; Lanier LL
    J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoultrastructural studies of human NK cells: II. Effector-target cell binding and phagocytosis.
    Kang YH; Carl M; Watson LP; Yaffe L
    Anat Rec; 1987 Mar; 217(3):290-304. PubMed ID: 3578843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
    Shanahan F; Brogan MD; Newman W; Targan SR
    J Immunol; 1986 Jul; 137(2):723-6. PubMed ID: 3487579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
    D'Orazio JA; Burke GW; Stein-Streilein J
    J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells.
    Kang YH; Carl M; Watson LP
    Scanning Microsc; 1988 Sep; 2(3):1567-86. PubMed ID: 3059478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
    Howell DN; Andreotti PE; Dawson JR; Cresswell P
    J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.